Krensavage Asset Management, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 18, 2026, for the 2025 Q4 period, Krensavage Asset Management, LLC held in its portfolio 18 assets valued at $283,112 (i.e. $283.11K).

The most valuable assets in the portfolio included: UNITED THERAPEUTICS CORP ($44.48K), ENANTA PHARMACEUTICALS INC ($43.63K), and BIOMARIN PHARMACEUTICAL INC ($31.19K).

The chart below shows the top 10 valuable assets, and the table below shows the top 18 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Krensavage Asset Management, LLC Portfolio

UNITED THERAPEUTICS CORP

ENANTA PHARMACEUTICALS INC

BIOMARIN PHARMACEUTICAL INC

JAZZ PHARMACEUTICALS PLC

EXELIXIS INC

AVADEL PHARMACEUTICALS

SANOFI-ADR

SUPERNUS PHARMACEUTICALS INC

CARDINAL HEALTH INC

INDIVIOR PLC

Krensavage Asset Management, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
UNITED THERAPEUTICS CORP	91282	44477	COM
ENANTA PHARMACEUTICALS INC	2766390	43626	COM
BIOMARIN PHARMACEUTICAL INC	524786	31188	COM
JAZZ PHARMACEUTICALS PLC	167816	28529	COM
EXELIXIS INC	493526	21631	COM
AVADEL PHARMACEUTICALS	855860	18444	COM
SANOFI-ADR	323946	15698	COM
SUPERNUS PHARMACEUTICALS INC	313499	15581	COM
CARDINAL HEALTH INC	73745	15155	COM
INDIVIOR PLC	339532	12182	COM
VANDA PHARMACEUTICALS INC	1180388	10411	COM
BIONTECH SE-ADR	99523	9475	COM
GSK PLC-SPON ADR	96729	4744	COM
ULTRAGENYX PHARMACEUTICAL IN	149634	3442	COM
REGENERON PHARMACEUTICALS	4000	3087	COM
ALKERMES PLC	107822	3017	COM
BIOGEN INC	10000	1760	COM
EVOLUS INC	100000	665	COM